Literature DB >> 11284484

Increase of free oxygen radicals in aqueous humour induced by selective Nd:YAG laser trabeculoplasty in the rabbit.

M Guzey1, H Vural, A Satici, S Karadede, Z Dogan.   

Abstract

PURPOSE: To investigate the impact of selective Nd:YAG laser trabeculoplasty on free oxygen radicals and antioxidant enzymes of the aqueous humour in the rabbit.
METHODS: One eye of 18 rabbits was subjected to 360 degrees selective laser trabeculoplasty (LT) with a frequency-doubled Nd:YAG laser (532 nm). The anterior chamber aqueous humour was aspirated 3, 12 hours and 1, 3, 7, 10 days after treatment. Lipid peroxide (LPO) and glutathione S transferase (GST) levels and superoxide dismutase (SOD) activities of aqueous humour were measured.
RESULTS: Concentrations of LPO in the aqueous humour of the treated eyes were significantly higher than the untreated eyes until the 7th day. Aqueous SOD activity significantly decreased 3 hours after LT and remained low until day 7. Aqueous GST levels were significantly decreased between 12 hours and 7 days after the LT.
CONCLUSIONS: Selective LT was followed by an immediate increase in the aqueous humour LPO concentration and decreases of SOD and GST in the rabbit, probably due to photovaporization and photodisruption caused by the frequency-doubled Nd:YAG laser. The increased aqueous LPO levels suggest that free oxygen radicals are formed in the pigmented trabecular meshwork during LT, and may be responsible for the inflammatory complications of this procedure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284484     DOI: 10.1177/112067210101100109

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  14 in total

1.  Selective laser trabeculoplasty induced changes in the thickness of ciliary body and iris evaluated by ultrasound biomicroscopy.

Authors:  Umit Aykan; Ilhami Salcan; Ozlem Yildirim; Dilaver Ersanli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-23       Impact factor: 3.117

Review 2.  Could adverse effects and complications of selective laser trabeculoplasty be decreased by low-power laser therapy?

Authors:  Alexandre de Carvalho Mendes Paiva; Adenilson de Souza da Fonseca
Journal:  Int Ophthalmol       Date:  2017-11-30       Impact factor: 2.031

Review 3.  Selective laser trabeculoplasty: past, present, and future.

Authors:  A Garg; G Gazzard
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

4.  Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome.

Authors:  G G Koliakos; A G P Konstas; U Schlötzer-Schrehardt; G Hollo; D Mitova; D Kovatchev; S Maloutas; N Georgiadis
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

5.  Trabecular meshwork gene expression after selective laser trabeculoplasty.

Authors:  Alberto Izzotti; Mariagrazia Longobardi; Cristina Cartiglia; Federico Rathschuler; Sergio Claudio Saccà
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

Review 6.  Selective laser trabeculoplasty: current perspectives.

Authors:  Kate E Leahy; Andrew Jr White
Journal:  Clin Ophthalmol       Date:  2015-05-11

7.  Evaluation of Color-Changing Effect and Complications After Nd: YAG Laser Application On Iris Surface.

Authors:  Yildiray Yildirim; Eyup Duzgun; Taner Kar; Murat Sonmez; Zafer Kucukodaci; Dilaver Ersanli; Ayhan Basoglu
Journal:  Med Sci Monit       Date:  2016-01-11

8.  Selective laser trabeculoplasty: Does energy dosage predict response?

Authors:  Larissa Habib; James Lin; Tamara Berezina; Bart Holland; Robert D Fechtner; Albert S Khouri
Journal:  Oman J Ophthalmol       Date:  2013-05

9.  Corneal decompensation after selective laser trabeculoplasty.

Authors:  Ahmet Ozkok; Nevbahar Tamcelik; Didar Ucar Comlekoglu; Guzin Iskeleli
Journal:  Case Rep Ophthalmol Med       Date:  2014-07-01

Review 10.  Complications of selective laser trabeculoplasty: a review.

Authors:  Julia Song
Journal:  Clin Ophthalmol       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.